Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181

Watchlist Manager
Zhejiang Jolly Pharmaceutical Co Ltd Logo
Zhejiang Jolly Pharmaceutical Co Ltd
SZSE:300181
Watchlist
Price: 16.3 CNY -1.87% Market Closed
Market Cap: 11.4B CNY
Have any thoughts about
Zhejiang Jolly Pharmaceutical Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Zhejiang Jolly Pharmaceutical Co Ltd

Revenue
2.4B CNY
Cost of Revenue
-865.8m CNY
Gross Profit
1.5B CNY
Operating Expenses
-932.6m CNY
Operating Income
560.8m CNY
Other Expenses
-79.5m CNY
Net Income
481.3m CNY

Income Statement
Zhejiang Jolly Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
440
N/A
457
+4%
515
+13%
572
+11%
620
+8%
657
+6%
671
+2%
721
+7%
810
+12%
819
+1%
840
+3%
830
-1%
814
-2%
804
-1%
794
-1%
762
-4%
744
-2%
724
-3%
730
+1%
764
+5%
767
+0%
859
+12%
911
+6%
901
-1%
950
+5%
1 024
+8%
1 091
+7%
1 238
+13%
1 322
+7%
1 400
+6%
1 457
+4%
1 557
+7%
1 655
+6%
1 723
+4%
1 805
+5%
1 861
+3%
1 922
+3%
1 926
+0%
1 942
+1%
2 120
+9%
2 359
+11%
Gross Profit
Cost of Revenue
(60)
(67)
(90)
(127)
(155)
(185)
(211)
(256)
(301)
(329)
(340)
(357)
(372)
(369)
(356)
(335)
(306)
(288)
(278)
(299)
(305)
(326)
(330)
(311)
(319)
(327)
(363)
(397)
(416)
(446)
(420)
(466)
(501)
(512)
(535)
(578)
(603)
(628)
(616)
(714)
(866)
Gross Profit
380
N/A
390
+3%
425
+9%
446
+5%
465
+4%
472
+1%
460
-2%
465
+1%
509
+9%
490
-4%
500
+2%
473
-5%
442
-6%
435
-2%
438
+1%
428
-2%
438
+2%
436
-1%
453
+4%
465
+3%
462
-1%
533
+15%
581
+9%
590
+1%
631
+7%
697
+11%
728
+4%
841
+16%
906
+8%
954
+5%
1 037
+9%
1 090
+5%
1 154
+6%
1 211
+5%
1 271
+5%
1 284
+1%
1 319
+3%
1 298
-2%
1 326
+2%
1 406
+6%
1 493
+6%
Operating Income
Operating Expenses
(301)
(305)
(322)
(336)
(353)
(367)
(374)
(376)
(418)
(414)
(435)
(408)
(377)
(368)
(375)
(374)
(380)
(386)
(408)
(429)
(444)
(496)
(526)
(545)
(578)
(618)
(602)
(676)
(714)
(744)
(805)
(831)
(870)
(903)
(931)
(918)
(920)
(879)
(892)
(907)
(933)
Selling, General & Administrative
(299)
(303)
(298)
(332)
(349)
(362)
(343)
(375)
(415)
(412)
(401)
(416)
(395)
(390)
(381)
(400)
(397)
(404)
(409)
(422)
(446)
(497)
(525)
(531)
(554)
(595)
(601)
(677)
(719)
(743)
(800)
(837)
(873)
(909)
(928)
(927)
(928)
(890)
(879)
(926)
(957)
Research & Development
0
0
(18)
0
0
0
(23)
0
0
0
(23)
0
0
(5)
(21)
0
0
(11)
(25)
(21)
(27)
(26)
(25)
(29)
(30)
(30)
(29)
(31)
(33)
(42)
(44)
(50)
(61)
(64)
(62)
(71)
(73)
(72)
(74)
(76)
(78)
Depreciation & Amortization
0
0
(7)
0
0
0
(8)
0
0
0
(12)
0
0
0
(12)
0
0
0
(16)
0
0
0
(17)
0
0
0
(16)
0
0
0
(16)
0
0
0
(21)
0
0
0
(26)
0
0
Other Operating Expenses
(2)
(2)
(0)
(3)
(3)
(4)
0
(1)
(4)
(2)
0
8
17
27
39
26
18
30
42
14
29
27
41
15
6
7
43
32
38
41
55
56
64
70
80
80
81
84
87
95
103
Operating Income
79
N/A
85
+8%
103
+21%
110
+7%
113
+2%
105
-7%
87
-18%
89
+3%
90
+2%
75
-17%
65
-14%
65
0%
65
+0%
67
+3%
63
-6%
53
-15%
58
+9%
50
-14%
45
-11%
37
-18%
18
-51%
36
+100%
56
+53%
44
-20%
53
+19%
79
+50%
126
+59%
166
+32%
192
+16%
209
+9%
232
+11%
259
+12%
284
+10%
308
+8%
339
+10%
366
+8%
398
+9%
420
+5%
434
+3%
499
+15%
561
+12%
Pre-Tax Income
Interest Income Expense
(1)
(2)
(3)
(4)
(6)
(5)
(7)
(7)
(8)
(1)
(7)
(7)
(7)
(16)
(11)
(13)
(17)
(20)
(1)
(5)
(2)
(1)
(17)
(16)
(18)
(16)
(16)
(14)
(11)
(9)
(7)
(6)
(4)
(5)
(4)
0
5
11
14
12
13
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
(7)
(0)
(0)
0
(10)
0
0
0
(12)
0
0
1
(9)
1
1
(0)
(0)
(0)
(0)
0
0
0
(0)
(0)
2
2
2
2
(0)
0
0
Gain/Loss on Disposition of Assets
0
0
(0)
0
0
0
(2)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
0
0
0
(11)
0
0
0
0
0
0
Total Other Income
23
24
21
21
27
27
27
25
28
33
44
23
28
16
20
18
1
3
1
1
0
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(0)
(1)
(0)
(3)
(3)
(2)
(2)
(13)
(13)
(14)
(2)
(12)
(12)
Pre-Tax Income
101
N/A
106
+6%
121
+13%
127
+5%
134
+5%
127
-5%
105
-17%
107
+2%
111
+3%
107
-3%
95
-11%
81
-15%
86
+7%
67
-22%
61
-8%
59
-4%
43
-28%
33
-21%
32
-5%
32
+2%
17
-49%
37
+122%
29
-20%
29
-2%
36
+25%
62
+73%
109
+76%
151
+38%
180
+19%
200
+11%
222
+11%
251
+13%
277
+10%
300
+9%
324
+8%
355
+10%
393
+11%
419
+7%
447
+7%
500
+12%
562
+13%
Net Income
Tax Provision
(11)
(11)
(14)
(14)
(15)
(15)
(12)
(12)
(13)
(12)
(13)
(11)
(14)
(10)
(8)
(8)
(5)
(5)
(6)
(6)
(2)
(6)
(5)
(5)
(6)
(8)
(14)
(20)
(24)
(29)
(30)
(33)
(36)
(35)
(39)
(43)
(48)
(55)
(56)
(64)
(73)
Income from Continuing Operations
90
95
107
113
118
112
94
95
98
96
82
69
72
56
53
51
38
29
26
27
14
30
24
24
30
54
95
131
156
170
192
218
241
266
286
312
345
364
391
435
489
Income to Minority Interest
0
(1)
(4)
(6)
(8)
(9)
(9)
(9)
(10)
(10)
(10)
(10)
(10)
(8)
(8)
(7)
(6)
(9)
(5)
(4)
(1)
3
2
2
(1)
(5)
(7)
(10)
(12)
(12)
(13)
(13)
(13)
(14)
(13)
(11)
(9)
(8)
(8)
(8)
(8)
Net Income (Common)
90
N/A
94
+5%
103
+10%
107
+4%
111
+3%
103
-7%
85
-18%
85
+1%
88
+3%
86
-2%
72
-16%
59
-18%
63
+6%
49
-22%
45
-8%
44
-3%
32
-28%
20
-37%
21
+5%
23
+8%
14
-39%
34
+146%
26
-24%
26
+0%
29
+12%
49
+71%
89
+80%
122
+37%
145
+19%
158
+9%
179
+14%
204
+14%
228
+11%
252
+11%
273
+8%
302
+11%
336
+11%
356
+6%
383
+8%
428
+12%
481
+12%
EPS (Diluted)
0.16
N/A
0.17
+6%
0.19
+12%
0.2
+5%
0.2
N/A
0.18
-10%
0.15
-17%
0.14
-7%
0.15
+7%
0.15
N/A
0.12
-20%
0.11
-8%
0.11
N/A
0.08
-27%
0.07
-13%
0.06
-14%
0.04
-33%
0.03
-25%
0.03
N/A
0.04
+33%
0.03
-25%
0.06
+100%
0.04
-33%
0.05
+25%
0.05
N/A
0.08
+60%
0.15
+88%
0.19
+27%
0.23
+21%
0.25
+9%
0.29
+16%
0.34
+17%
0.37
+9%
0.41
+11%
0.45
+10%
0.43
-4%
0.47
+9%
0.52
+11%
0.55
+6%
0.61
+11%
0.69
+13%

See Also

Discover More